Agility will be the focus for Pharmaceutical and Medical Device Markets in 2016, says AMPLEXOR Life Sciences Wednesday 9 December 2015 PDF Print Without a consistent, holistic approach to all forms of content, life sciences companies will never be truly agile The newly branded technology & services group warns that current market pressures demand a more holistic approach to global data handling Bertrange, Luxembourg - December 9th, 2015 – Until the life sciences industry treats content management holistically, its ability to seize new market opportunities may be limited. So says Mark Evenepoel, group CEO of AMPLEXOR – the newly branded 360-degree content management corporation which brings together four technology and services powerhouses: euroscript, INFOTEHNA, ForeignExchange Translations, and Amplexor. The combined group, rebranded as AMPLEXOR, will incorporate the AMPLEXOR Life Sciences brand as of today, and specializes in helping life sciences organizations accelerate their speed to market and enter new countries quickly. Its solutions and services expedite the creation and delivery of consistent, compliant and high-quality global content – both physical and digital – across all of a company’s target markets. “Without a consistent, holistic approach to all forms of content, life sciences companies will never be truly agile,” Evenepoel warns. “The industry knows that, and I believe 2016 will be a turning point.” His comments chime with research published by Gens & Associates (Next Generation Content Management “Pulse Survey”) in April. This suggests that life sciences organizations which manage their content at a holistic, pan-enterprise level derive greater value from their investments. All companies surveyed expect to move towards an enterprise-wide approach to content management governance within the next 2-5 years, as they strive to create a global authoritative source of content and information sharing. “Silos hamper speed to market. They risk inaccuracy, and compromise the ability to deliver correct content quickly to where it’s needed,” Evenepoel notes. “Content management in the life sciences industry must transcend individual initiatives such as IDMP [Identification of Medical Products] compliance. Companies need a reliable way to manage not just what’s submitted to regulators, but also what goes out on the packaging, and on their web site, and what’s distributed across digital and social media – in every region and every country.” Employing 1,600 people in 24 countries across four continents, AMPLEXOR Life Sciences has a 30+ year history of serving the biggest names in the pharmaceutical, medical device and biotechnology markets. It combines euroscript, a leading life sciences content management implementation specialist; INFOTEHNA, with its powerful content management platform and leading suite of life sciences solutions; ForeignExchange Translations, which provides expert professional medical translation, and Amplexor, a digital experience platform for managing content across web, mobile and social channels. With its comprehensive technology solutions and professional services, spanning all forms of physical and digital content, AMPLEXOR Life Sciences is a leading, visionary one-stop-shop partner for life sciences companies. Its services include technology consultancy, implementation and management services; technical writing & linguistic services, and marketing asset creation and management. “We’re very excited about the year ahead,” says Evenepoel, who before the rebranding was CEO of euroscript. “Pharma, medical device manufacturers and biotech firms face some significant challenges in 2016 as they align themselves with the latest regulatory reporting requirements while simultaneously racing competitors to bring out new products and enter new markets. “There is so much going on for the sector right now. What we’re offering them is a lasting solution to one of the core challenges: managing all of the content and keeping it compliant and consistent wherever it appears ─ and ready to go as soon as it’s needed.” About AMPLEXOR Life Sciences AMPLEXOR Life Sciences helps pharmaceutical, medical device and biotechnology organizations launch products and break new markets quickly. Its solutions and services expedite the creation and delivery of consistent, compliant and high-quality global content – both physical and digital – across all target countries. Its services include technology consultancy, implementation and management services, as well as technical writing, medical translation and linguistic validation services, and the creation and management of marketing assets. Headquartered in Bertrange, Luxembourg, AMPLEXOR employs 1,600 people in 24 countries across four continents. It boasts a rich 30+ year history of serving the biggest names in pharma, medical device manufacturing and biotech. More at www.amplexor.com and @amplexor on Twitter. PR Contact Carina Birt, Sarum PR for Amplexor email@example.com +44 1722 322916 Note to editors: The AMPLEXOR Life Sciences brand was launched in December 2015. It combines the businesses of euroscript, Infotehna Group, ForeignExchange Translations, and Amplexor. Euroscript, a leading life sciences content management implementation company, acquired the other three companies over the last 18 months. This press release was distributed by ResponseSource Press Release Wire on behalf of Sarum PR in the following categories: Business & Finance, Medical & Pharmaceutical, Computing & Telecoms, for more information visit http://pressreleasewire.responsesource.com/about.